Search for: "MERCK " Results 761 - 780 of 3,309
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jun 2015, 8:52 pm by Patent Docs
• Defendants: Merck & Co., Inc.; Merck Sharp & Dohme Corp.; N.V. [read post]
15 Jun 2015, 3:57 am by Derek T. Braslow
Among the PPIs identified in the study as linked to an increased risk of heart attack, the following are common in prescription or over- the-counter form: • Prilosec – manufactured by AstraZeneca • Prilosec OTC – manufactured by Procter & Gamble • Nexium – manufactured by AstraZeneca and now available over the counter • Zegerid OTC – manufactured by Merck & Col and Santarus, Inc. [read post]
2 Jun 2015, 12:18 pm by Ronald V. Miller, Jr.
 If there is a injury or death, you can expect Merck to settle the case quickly. [read post]
29 May 2015, 6:00 am by Steven Malman
Manufacturers Organon and Merck have faced lawsuits from over 1,000 women. [read post]
29 May 2015, 6:00 am by Steven Malman
Manufacturers Organon and Merck have faced lawsuits from over 1,000 women. [read post]
12 May 2015, 3:26 pm by James Galvin
Inc. 902641802 UBS Yield Optimization Securities with Contingent Protection linked to McDonald’s Corp. 902641851 UBS Yield Optimization Securities with Contingent Protection linked to Schlumberger, Ltd. 902641869 UBS Yield Optimization Securities with Contingent Protection linked to Oracle Corp. 902641877 UBS Yield Optimization Securities with Contingent Protection linked to Dell Inc. 902641885 UBS Yield Optimization Securities with Contingent Protection linked to AT&T Inc. 902644186 UBS… [read post]
25 Apr 2015, 11:03 am by Schachtman
The first edition of the Reference Manual on Scientific Evidence [Manual] was published in 1994, a year after the Supreme Court delivered its opinion in Daubert. [read post]
10 Apr 2015, 3:00 am by Steve Brachmann
The early months of 2015 have been interesting ones for the pharmaceutical industry, an incredibly valuable industry sector that comes under our focus from time to time here at IPWatchdog. [read post]
10 Apr 2015, 3:00 am by Steve Brachmann
The early months of 2015 have been interesting ones for the pharmaceutical industry, an incredibly valuable industry sector that comes under our focus from time to time here at IPWatchdog. [read post]
10 Apr 2015, 3:00 am by Steve Brachmann
The early months of 2015 have been interesting ones for the pharmaceutical industry, an incredibly valuable industry sector that comes under our focus from time to time here at IPWatchdog. [read post]
10 Apr 2015, 3:00 am by Steve Brachmann
The early months of 2015 have been interesting ones for the pharmaceutical industry, an incredibly valuable industry sector that comes under our focus from time to time here at IPWatchdog. [read post]
3 Apr 2015, 6:12 am by Rebecca Tushnet
But: Merck case: enhanced damages can serve compensatory purposes when harm difficult to quantify and deterrent purposes when violation was willful. [read post]
28 Mar 2015, 3:26 am by Jon Gelman
”The PREVAIL trial, which began on Feb. 2, 2015 in Monrovia, Liberia, is testing the safety and efficacy of the cAd3-EBOZ candidate vaccine co-developed by NIAID scientists and GlaxoSmithKline, and the VSV-ZEBOV candidate vaccine developed by the Public Health Agency of Canada and licensed to NewLink Genetics Corporation and Merck. [read post]